Compugen Reports 22-Percent Slide in Q3 Revenue, Names New CEO | GenomeWeb

NEW YORK, Nov. 2 (GenomeWeb News) - Compugen said today that revenues for the third quarter declined 22 percent while net losses remained flat.

 

The company also said it has named Alex Kotzer president and CEO. He started on Sept. 1.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.